TCS PrP Inhibitor 13

• CAT Number: I010726
• CAS Number: 34320-83-7
• Molecular Formula: C15H11N3O3
• Molecular Weight: 281.27
• Purity: ≥95%
• Synonyms: 2,4-Dihydro-5-(4-nitrophenyl)-2-phenyl-3H-pyrazol-3-one
• Target: Apoptosis
• Solubility: Soluble to 100 mM in DMSO and to 25 mM in ethanol
• Storage: Store at +4℃
• IUPAC Name: 5-(4-nitrophenyl)-2-phenyl-4H-pyrazol-3-one
• InChI: InChI=1S/C15H11N3O3/c19-15-10-14(11-6-8-13(9-7-11)18(20)21)16-17(15)12-4-2-1-3-5-12/h1-9H,10H2
• InChIKey: FDAVFKZPGQEGDX-UHFFFAOYSA-N
• SMILES: C1C(=NN(C1=O)C2=CC=CC=C2)C3=CC=C(C=C3)[N+](=O)[O-]

TCS PrP Inhibitor 13 (Cat No.: I010726) is a compound designed to target and inhibit prion protein (PrP) aggregation, a key factor in prion diseases such as Creutzfeldt-Jakob disease and mad cow disease. By preventing the misfolding and accumulation of PrP, TCS PrP Inhibitor 13 has shown potential in reducing neurodegeneration and cellular toxicity associated with prion diseases. Its efficacy is being explored in preclinical studies, and it represents a promising therapeutic approach for treating these rare and devastating neurodegenerative conditions.